AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

China $9 Billion Vaccine Market & Doses Forecast to 2025 By Sector (Private, Public), Disease Type, Products, Company - Opportunity in the Implementation of the Two Child Policy - ResearchAndMarkets.com

December 18, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Dec 18, 2019--

The “China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type, Products, Company” report has been added to ResearchAndMarkets.com’s offering.

China Vaccine Market has great potential due to its vast population; so, its market size is projected to cross over US$ 9 Billion by 2025.

Vaccines are developed to address the public health needs. In China, vaccines are available through the government programmed called Expanded Program on Immunization and are free for all children up to 14 years of age. However private sector vaccines such as Rabies Vaccine, Influenza Vaccine and Haemophilus Influenza Type B vaccine are also available in China but are usually paid for out-of-pocket as these are neither include in government EPI program nor government health insurance schemes.

China vaccine market is divided into public and private vaccine market. Public market is classified by Category 1 whereas and Private vaccines included in Category 2. Vaccines in the public market are regulated by PRC government and generally given free of cost by provincial CDC whereas private vaccine market is dominating by private vaccine companies. As a result, private vaccines prices are higher. China vaccine market has faced several scandals in past couple of years which certainly hinder the vaccine market growth.

Market Dynamics

Growth Drivers

Challenges

Opportunities

Sectors - Vaccine Market & Doses in China

Disease Type Market - Meningococcal Meningitis, Pneumococcal and DTP Vaccine Market has significant Market Share in China Vaccine Market

On the basis of disease type, Meningococcal meningitis, Pneumococcal and DTP Vaccine market is expected to control major portion of China vaccine market. Vaccine market in China is segmented into Meningococcal meningitis, Pneumococcal, DTP, Ebola, Rabies & Others.

Products - PCV13 Drives Vaccine Market in China

In terms of products, PCV13 hold the maximum share of the China vaccine market. It is predicted that PCV13 will maintain their leading place during the forecasting period as well. Products included in this report are as follows:

Public and Private Vaccine Market & Doses

This report provides the detailed analysis of public and private vaccine market in China. Report also provides private and public vaccine doses in China.

Company Analysis

All the companies covered in the report has been covered from the following points

Key Company Covered - China Vaccine Market

For more information about this report visit https://www.researchandmarkets.com/r/pc8l1d

View source version on businesswire.com:https://www.businesswire.com/news/home/20191218005496/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: CHINA ASIA PACIFIC

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/18/2019 10:05 AM/DISC: 12/18/2019 10:05 AM

http://www.businesswire.com/news/home/20191218005496/en